drugset / Trial / NCT03281187
Efficacy and Safety of Testosterone Nasal Gel for Treating Hypogonadism in Men.
Phase 3
Unknown
228 enrolled
FBM Industria Brasileira Ltda
Azidus Brasil Scientific Research and Development Ltda · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a phase III study for evaluation of Nasotestt efficacy compared to Androgel in the treatment of male participants with hypogonadism condition (reduced levels of testosterone) that have clinical indication of hormonal replacement with testosterone.
Timeline
- Start
- 2018-07-16
- Primary completion
- 2018-11-12
- Completion
- 2020-01-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Testosterone | Small molecule | 5 mg | Intranasal |
| Subject | Testosterone | Small molecule | 50 mg | Intranasal |